Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models
Open Access
- 1 December 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 28 (23) , 3940-3953
Abstract
G4C2 repeat expansions in an intron of C9ORF72 cause the most common familial amyotrophic lateral sclerosis and frontotemporal dementia (collectively, C9ALS/FTD). Mechanisms and mediators of C9ALS/FTD pathogenesis remain poorly understood. C9orf72 and Smcr8 form a protein complex. Here, we show that expression of Smcr8, like C9orf72, is reduced in C9ALS/FTD mouse models and patient tissues. Since Smcr8 is highly conserved between human and mouse, we evaluated the effects of Smcr8 downregulation in mice. Smcr8 knockout (KO) mice exhibited motor behavior deficits, which resemble those of C9ALS/FTD mouse models, and displayed axonal swellings in their spinal cords and neuromuscular junctions. These deficits are caused by impaired autophagy-lysosomal functions due to disrupted axonal transport in mutant motor neurons. Consistent with its interaction with C9orf72 and their downregulation in patient tissues, Smcr8 deficiency exacerbated autophagy-lysosomal impairment in C9orf72 KO mice. The disease relevance of Smcr8 downregulation was reflected by exacerbated axonal swellings and gain of toxicity pathology arising from Smcr8 haploinsufficiency in a mouse model of C9ALS/FTD. Thus, our in vivo studies suggested that Smcr8 deficiency impairs axonal transport dependent autophagy-lysosomal function and exacerbates axonal degeneration and gain of toxicity in C9ALS/FTD mouse models.Keywords
Funding Information
- University of Southern California (R01NS097231, R01NS096176)
- National Institutes of Health
This publication has 52 references indexed in Scilit:
- C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent mannerActa Neuropathologica Communications, 2019
- Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neuronsNature Medicine, 2018
- Dysregulated molecular pathways in amyotrophic lateral sclerosis–frontotemporal dementia spectrum disorderThe EMBO Journal, 2017
- Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansionNeurobiology of Aging, 2014
- C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA fociActa Neuropathologica, 2013
- Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein HomeostasisNeuron, 2013
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyThe Lancet Neurology, 2012
- A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyThe Lancet Neurology, 2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011